Eli Lilly & Co. revenue breakdown overview

Eli Lilly & Co. revenue for the last year amounted to 30.92 B EUR, the most of which — 30.92 B EUR — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 26.67 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Eli Lilly & Co. 19.74 B EUR, and the year before that — 17.00 B EUR.